UPEC Pathway to Chronicity: Bacterial Strain and Host Differences Determine Chronic Outcomes (#223)
Michelle N Chamoun
1
,
Matthew J Sullivan
1
,
Deepak S Ipe
1
,
Mark A Schembri
2
3
,
Glen C Ulett
1
- School of Medical Science, Menzies health institute Queensland, Griffith Univerisity, Southport, Queensland, Australia
- School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia
- Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, Queensland, Australia
Publish consent withheld
- Foxman, B., et al., Urinary tract infection: self-reported incidence and associated costs. Annals of Epidemiology, 2000. 10(8): p. 509-15.
- Foxman, B., The epidemiology of urinary tract infection. Nature Reviews. Urology, 2010. 7(12): p. 653-60.
- Hannan, T.J., et al., Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathogens, 2010. 6(8): p. e1001042.
- Schwartz, D.J., et al., Uropathogenic Escherichia coli Superinfection Enhances the Severity of Mouse Bladder Infection. PLoS Pathogens, 2015. 11(1): p. e1004599
- O'Brien, V.P., et al., A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease. Nat Microbiol, 2016. 2: p. 16196.
- Sivick, K.E., et al., The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. Journal of Immunology, 2010. 184(4): p. 2065-75.